English  |  正體中文  |  简体中文  |  总笔数 :2822924  
造访人次 :  30095641    在线人数 :  859
教育部委托研究计画      计画执行:国立台湾大学图书馆
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
关于TAIR

浏览

消息

著作权

相关连结

"hsu c l"的相关文件

回到依作者浏览
依题名排序 依日期排序

显示项目 416-440 / 696 (共28页)
<< < 12 13 14 15 16 17 18 19 20 21 > >>
每页显示[10|25|50]项目

机构 日期 题名 作者
臺大學術典藏 2020-03-31T08:54:34Z Apoptosis-associated biomarkers in tuberculosis: Promising for diagnosis and prognosis prediction Yang P.-C.; LI-NA LEE; Yu C.-J.; Shu C.-C.; Wu M.-F.; Hsu C.-L.; Huang C.-T.; Wang J.-Y.; Hsieh S.-L.
臺大學術典藏 2020-03-31T08:54:31Z Tuberculosis mortality: Patient characteristics and causes LI-NA LEE; Cheng W.-C.; Chen J.-M.; Hsu C.-L.; Wang J.-Y.; Kuo Y.-W.; Lin C.-J.; Lin C.-H.
臺大學術典藏 2020-03-31T08:54:29Z Gender-Dimorphic Impact of PXR Genotype and Haplotype on Hepatotoxicity During Antituberculosis Treatment Wang J.Y.; Tsai C.H.; Lee Y.L.; LI-NA LEE; Hsu C.L.; Chang H.C.; Chen J.M.; Hsu C.A.; Yu C.J.; Yang P.C.
臺大學術典藏 2020-03-31T08:54:29Z Comparison of the prevalence of latent tuberculosis infection among non-dialysis patients with severe chronic kidney disease, patients receiving dialysis, and the dialysis-unit staff a cross-sectional study LI-NA LEE; Wang J.-T.; Yu C.-J.; Yang F.-J.; Wu V.-C.; Wang J.-Y.; Lee C.-Y.; Shu C.-C.; Hsu C.-L.
臺大學術典藏 2020-03-31T08:54:28Z Risk of tuberculosis among patients on dialysis Yu C.-J.; LI-NA LEE; Chen J.-S.; Wang J.-Y.; Yang F.-J.; Lin H.-H.; Wu V.-C.; Liou H.-H.; Lee C.-Y.; Wei Y.-F.; Hsu C.-L.; Shu C.-C.
臺大學術典藏 2020-03-31T08:54:27Z The trend and the disease prediction of vascular endothelial growth factor and placenta growth factor in nontuberculous mycobacterial lung disease Lin C.-H.; Shu C.-C.; Hsu C.-L.; Cheng S.-L.; Wang J.-Y.; Yu C.-J.; LI-NA LEE
臺大學術典藏 2020-03-31T08:54:27Z Inflammatory markers and clinical characteristics for predicting persistent positivity of interferon gamma release assay in dialysis population LI-NA LEE; Yu C.-J.; Yang F.-J.; Wang J.-Y.; Wu V.-C.; Lee C.-Y.; Hsu C.-L.; Shu C.-C.
臺大學術典藏 2020-03-30T08:50:44Z Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutations Yu C.-J.; Yang J.C.-H.; Shih J.-Y.; Lin Z.-Z.; Lee J.-H.; Chen K.-Y.; Yang C.-Y.; Hsu C.-L.; Ho C.-C.; Lin Y.-T.;Jin-Shing Chen;Liao W.-Y.;Ho C.-C.;Hsu C.-L.;Yang C.-Y.;Chen K.-Y.;Lee J.-H.;Lin Z.-Z.;Shih J.-Y.;Yang J.C.-H.;Yu C.-J.; Lin Y.-T.; JIN-SHING CHEN; Liao W.-Y.
臺大學術典藏 2020-03-27T05:30:03Z Adding moxifloxacin is associated with a shorter time to culture conversion in pulmonary tuberculosis Yang P.-C.; Lee L.-N.; PO-REN HSUEH; Yu C.-J.; Hsu C.-L.; Wang J.-T.; Tsai T.-H.; Wang J.-Y.; Yang P.-C.;Lee L.-N.;PO-REN HSUEH;Yu C.-J.;Hsu C.-L.;Tsai T.-H.;Wang J.-T.;Wang J.-Y.
臺大學術典藏 2020-03-23T05:53:56Z Quantitative Proteomics of Th-MYCN Transgenic Mice Reveals Aurora Kinase Inhibitor Altered Metabolic Pathways and Enhanced ACADM to Suppress Neuroblastoma Progression Juan H.-F.; Huang H.-C.; Hsu W.-M.; CHIUNG-NIEN CHEN; Chen S.-F.; Yang T.-S.; Huang C.-T.; Hsu C.-L.; Hou C.-L.; Liu Y.-L.; Cheung C.H.Y.; Hsieh C.-H.; Hsieh C.-H.;Cheung C.H.Y.;Liu Y.-L.;Hou C.-L.;Hsu C.-L.;Huang C.-T.;Yang T.-S.;Chen S.-F.;Chiung-Nien Chen;Hsu W.-M.;Huang H.-C.;Juan H.-F.
臺大學術典藏 2020-03-07T06:56:14Z Histologic Transformation in a Patient with Lung Cancer Treated with Chemotherapy and Pembrolizumab Hsu C.-L.;Chen K.-Y.;Kuo S.-W.;Yih-Leong Chang; Hsu C.-L.; Chen K.-Y.; Kuo S.-W.; YIH-LEONG CHANG
臺大學術典藏 2020-03-07T06:56:12Z Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan Lin S.-Y.;Yang C.-Y.;Liao B.-C.;Ho C.-C.;Liao W.-Y.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Hsu W.-H.;Su K.-Y.;Yih-Leong Chang;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.;Yu C.-J.; Lin S.-Y.; Yang C.-Y.; Liao B.-C.; Ho C.-C.; Liao W.-Y.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Hsu W.-H.; Su K.-Y.; YIH-LEONG CHANG; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.; Yu C.-J.
臺大學術典藏 2020-03-07T06:56:11Z IGFBP7 Drives resistance to epidermal growth factor receptor tyrosine kinase inhibition in lung cancer Tsai M.-F.; Liu Y.-N.; Hsu C.-L.; YIH-LEONG CHANG; Yu C.-J.; Shih J.-Y.; Wu S.-G.;Chang T.-H.;Tsai M.-F.;Liu Y.-N.;Hsu C.-L.;Yih-Leong Chang;Yu C.-J.;Shih J.-Y.; Wu S.-G.; Chang T.-H.
臺大學術典藏 2020-03-07T06:56:09Z Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors Yang C.-Y.;Liao W.-Y.;Ho C.-C.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Su K.-Y.;Yih-Leong Chang;Wu C.-T.;Hsu C.-C.;Liao B.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.-H.;Yu C.-J.; Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Su K.-Y.; YIH-LEONG CHANG; Wu C.-T.; Hsu C.-C.; Liao B.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J.
臺大學術典藏 2020-03-06T08:24:45Z Reliability of a single-region sample to evaluate tumor immune microenvironment in hepatocellular carcinoma Shen Y.-C.;Hsu C.-L.;Yung-Ming Jeng;Ho M.-C.;Ho C.-M.;Yeh C.-P.;Yeh C.-Y.;Hsu M.-C.;Hu R.-H.;Cheng A.-L.; Shen Y.-C.; Hsu C.-L.; YUNG-MING JENG; Ho M.-C.; Ho C.-M.; Yeh C.-P.; Yeh C.-Y.; Hsu M.-C.; Hu R.-H.; Cheng A.-L.
臺大學術典藏 2020-03-06T05:26:05Z Histologic Transformation in a Patient with Lung Cancer Treated with Chemotherapy and Pembrolizumab Hsu C.-L.; Chen K.-Y.; Kuo S.-W.; YIH-LEONG CHANG
臺大學術典藏 2020-03-06T05:26:04Z Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan Lin S.-Y.; Yang C.-Y.; Liao B.-C.; Ho C.-C.; Liao W.-Y.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Hsu W.-H.; Su K.-Y.; YIH-LEONG CHANG; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.; Yu C.-J.
臺大學術典藏 2020-03-06T05:26:02Z IGFBP7 Drives resistance to epidermal growth factor receptor tyrosine kinase inhibition in lung cancer Wu S.-G.; Chang T.-H.; Tsai M.-F.; Liu Y.-N.; Hsu C.-L.; YIH-LEONG CHANG; Yu C.-J.; Shih J.-Y.
臺大學術典藏 2020-03-06T05:26:00Z Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Su K.-Y.; YIH-LEONG CHANG; Wu C.-T.; Hsu C.-C.; Liao B.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J.
臺大學術典藏 2020-03-05T08:38:05Z Impaired exercise capacity in diabetic patients after coronary bypass surgery: Effects of diastolic and endothelial function Wu Y.-W.;Hsu C.-L.;Shoei-Shen Wang;Tsai M.-W.;Chu S.-H.;Chen Y.-S.;Yang W.-S.;Wu Y.-T.; Wu Y.-W.; Hsu C.-L.; SHOEI-SHEN WANG; Tsai M.-W.; Chu S.-H.; Chen Y.-S.; Yang W.-S.; Wu Y.-T.
臺大學術典藏 2020-03-05T03:20:09Z Co-expression analysis identifies long noncoding RNA SNHG1 as a novel predictor for event-free survival in neuroblastoma Sahu D.; Hsu C.-L.; Lin C.-C.; Yang T.-W.; WEN-MING HSU; Ho S.-Y.; Juan H.-F.; Huang H.-C.
臺大學術典藏 2020-03-05T03:20:09Z Unveiling MYCN regulatory networks in neuroblastoma via integrative analysis of heterogeneous genomics data Hsu C.-L.; Chang H.-Y.; Chang J.-Y.; WEN-MING HSU; Huang H.-C.; Juan H.-F.
臺大學術典藏 2020-03-05T03:20:03Z Combinatorial targeting of MTHFD2 and PAICS in purine synthesis as a novel therapeutic strategy Cheung C.H.Y.;Hsu C.-L.;Tsuei C.-Y.;Kuo T.-T.;Huang C.-T.;Wen-Ming Hsu;Chung Y.-H.;Wu H.-Y.;Hsu C.-C.;Huang H.-C.;Juan H.-F.; Cheung C.H.Y.; Hsu C.-L.; Tsuei C.-Y.; Kuo T.-T.; Huang C.-T.; WEN-MING HSU; Chung Y.-H.; Wu H.-Y.; Hsu C.-C.; Huang H.-C.; Juan H.-F.
臺大學術典藏 2020-03-05T03:20:03Z Quantitative Proteomics of Th-MYCN Transgenic Mice Reveals Aurora Kinase Inhibitor Altered Metabolic Pathways and Enhanced ACADM to Suppress Neuroblastoma Progression Hsieh C.-H.; Cheung C.H.Y.; Liu Y.-L.; Hou C.-L.; Hsu C.-L.; Huang C.-T.; Yang T.-S.; Chen S.-F.; Chen C.-N.; WEN-MING HSU; Huang H.-C.; Juan H.-F.
臺大學術典藏 2020-03-02T06:05:22Z Knockdown of GALNT1 suppresses malignant phenotype of hepatocellular carcinoma by suppressing EGFR signaling Huang M.-J.; Hu R.-H.; Chou C.-H.; Hsu C.-L.; Liu Y.-W.; Huang J.; Hung J.-S.; Lai I.-R.; Juan H.-F.; Yu S.-L.; Wu Y.-M.; MIN-CHUAN HUANG

显示项目 416-440 / 696 (共28页)
<< < 12 13 14 15 16 17 18 19 20 21 > >>
每页显示[10|25|50]项目